Sabby Management’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

Sabby Management’s Portfolio ONTXW Stock Details ONTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-631,812	Closed	-$13K	–	101
2019 Q3	$13K	Sell	631,812 -10,500	-2%	-$736	0.01%	90
2019 Q2	$115K	Buy	642,312 +950	+0.1%	+$143	0.14%	66
2019 Q1	$35K	Sell	641,362 -19,608	-3%	-$2.49K	0.02%	65
2018 Q4	$26K	Sell	660,970 -4,500	-0.7%	-$383	0.01%	107
2018 Q3	$67K	Buy	665,470 +11,451	+2%	+$1.83K	0.01%	108
2018 Q2	$8K	Hold	654,019	–	–	﹤0.01%	132
2018 Q1	$196K	Buy	654,019 +10,775	+2%	+$4.04K	0.02%	121
2017 Q4	$225K	Sell	643,244 -2,106	-0.3%	-$1.25K	0.02%	122
2017 Q3	$252K	Hold	645,350	–	–	0.02%	122
2017 Q2	$290K	Sell	645,350 -5,400	-0.8%	-$3.25K	0.02%	164
2017 Q1	$544K	Sell	650,750 -40,322	-6%	-$28.9K	0.03%	172
2016 Q4	$428K	Sell	691,072 -34,362	-5%	-$30.8K	0.02%	205
2016 Q3	$1.12M	Buy	+725,434	New	+$768K	0.04%	172

Other funds holding ONTXW

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sabby Management's ONTXW Position: Q4 2019 in Review

Sabby Management sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q4 2019, closing a stake of 631,812 shares — an estimated $13K sold.

Sabby Management first reported a position in ONTXW in Q3 2016 and held it in 13 quarters. The position peaked at $1.12M in Q3 2016. 3 funds tracked by Wall St. Rank hold ONTXW as of Q4 2019.

Sabby Management reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q4 2019 after selling out during the quarter.
Sabby Management sold 631,812 Onconova Therapeutics, Inc. Warrants shares in Q4 2019, an estimated $13K.
Sabby Management first reported a position in Onconova Therapeutics, Inc. Warrants in Q3 2016 and held it in 13 quarters.
Sabby Management's Onconova Therapeutics, Inc. Warrants position peaked at $1.12M in Q3 2016.
3 funds tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q4 2019.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.